
The study unveiled the crucial role of dendritic cells (DCs) in bone substitute material implantation. Scientists discovered that surgical trauma during implantation triggers necrocytosis and releases high mobility group protein-1 (HMGB1). This protein adheres to substitute materials, activating DCs via the TLR4-MYD88-NFκB pathway, igniting inflammation. This breakthrough highlights the immune-regeneration link post-implantation, offering prospects for enhanced bone substitutes and refined surgical methods.
Like
Save
Share